PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dipartimento di Malattie infettive, Istituto Superiore di Sanità, Roma, Italy.\', \'Dipartimento Sicurezza alimentare, nutrizione e sanità pubblica veterinaria, Istituto Superiore di Sanità, Roma, Italy.\', \'Dipartimento di Oncologia e Medicina Molecolare, Istituto Superiore di Sanità, Roma, Italy.\', \'Centro nazionale per la salute globale, Istituto Superiore di Sanità, Roma, Italy.\', \'Department of Infectious Disease, Imperial College, London, United Kingdom.\', \'Centro per la sperimentazione ed il benessere animale, Istituto Superiore di Sanità, Roma, Italy.\', \'Centro nazionale per il controllo e la valutazione dei farmaci, Istituto Superiore di Sanità, Roma, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.750386
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34764961
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34764961>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34764961>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all